Cleveland Diagnostics is developing a breakthrough technology to discover a new class of diagnostics tests with high sensitivity and specificity for many cancers – early on, when cancer is still curable.
View Top Employees from Cleveland Diagnostics, Inc.Website | http://www.clevelanddx.com |
Revenue | $4 million |
Funding | $2.1 million |
Employees | 59 (39 on RocketReach) |
Founded | 2013 |
Address | 3615 Superior Avenue, Cleveland, Ohio 44114, US |
Phone | (216) 432-2700 |
Industry | Biotechnology Research, Business Services General, Biotechnology, Prostate Cancer, Business Services, Science and Engineering, Cancer Diagnostics, Health Care, Health Diagnostics |
Web Rank | 29 Million |
Keywords | Isopsa |
Competitors | Agendia, Contextual Genomics, MetaStat, Inc., Novigenix SA, Proteomedix AG |
SIC | SIC Code 87 Companies, SIC Code 873 Companies |
NAICS | NAICS Code 54 Companies, NAICS Code 62151 Companies, NAICS Code 621 Companies, NAICS Code 6215 Companies, NAICS Code 541 Companies, NAICS Code 62 Companies |
Looking for a particular Cleveland Diagnostics, Inc. employee's phone or email?
The Cleveland Diagnostics, Inc. annual revenue was $4 million in 2024.
Mark Stovsky is the Chief Medical Officer of Cleveland Diagnostics, Inc..
39 people are employed at Cleveland Diagnostics, Inc..
Cleveland Diagnostics, Inc. is based in Cleveland, Ohio.
The NAICS codes for Cleveland Diagnostics, Inc. are [54, 62151, 621, 6215, 541, 62].
The SIC codes for Cleveland Diagnostics, Inc. are [87, 873].